ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 340

$1.66M Total Retail Price of All Prescriptions

Rank: 4 out of 340

334 Patients Receiving at Least One Drug in Part D
26% Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Wisconsin
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

24% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$130 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
ALPRAZOLAM 745 65 105 B 1 12
QUETIAPINE FUMARATE 685 136 70 A 2 2
CLONAZEPAM 583 53 75 B 3 1
CYMBALTA 572 91 71 4 17
CLOZAPINE 392 0 22 A 5 16
LORAZEPAM 385 61 45 B 6 3
BUPROPION XL 374 66 48 7 21
ABILIFY 367 39 41 A 8 7
OLANZAPINE 353 28 36 A 9 9
RISPERIDONE 332 43 46 A 10 4
TOPIRAMATE 319 <11 34 11 33
AMPHETAMINE SALT COMBO 316 12 40 S2 12 30
TRAZODONE HCL 304 53 52 13 5
VENLAFAXINE HCL ER 263 54 30 14 13
LEVOTHYROXINE SODIUM 257 18 33 15 49
ZIPRASIDONE HCL 251 19 25 A 16 22
FLUOXETINE HCL 250 12 30 17 10
ZOLPIDEM TARTRATE 239 40 34 18 15
TEMAZEPAM 227 48 32 B 19 34
LAMOTRIGINE 222 50 29 20 8
SERTRALINE HCL 218 65 31 21 6
METHYLPHENIDATE HCL 215 51 30 S2 22 43
MIRTAZAPINE 157 66 23 23 19
DIAZEPAM 131 26 17 B 24 29
BENZTROPINE MESYLATE 129 0 15 R 25 11
TRIHEXYPHENIDYL HCL 125 13 18 R 26 35
CHLORPROMAZINE HCL 117 0 15 A 27 65
GABAPENTIN 114 <11 26 28 31
LITHIUM CARBONATE 112 26 15 29 18
LYRICA 112 18 16 29 73
CITALOPRAM HBR 109 22 21 31 14
DOXEPIN HCL 106 23 14 32 61
AMITRIPTYLINE HCL 105 <11 19 R 33 53
PRAZOSIN HCL 99 25 14 34 57
NAMENDA 99 44 11 34 38
DIVALPROEX SODIUM ER 97 17 12 36 20
OMEPRAZOLE 84 <11 13 37 60
BACLOFEN 83 <11 15 38 101
LEVETIRACETAM 73 <11 <11 39 105
RISPERDAL CONSTA 71 <11 <11 A 40 32
CARBAMAZEPINE 69 <11 <11 41 41
SEROQUEL 68 <11 <11 A 10 42 104
PERPHENAZINE 66 <11 <11 A 43 72
BUPROPION HCL SR 62 <11 <11 44 26
AMOXAPINE 60 <11 <11 10 45 128
ROPINIROLE HCL 59 <11 <11 46 129
VENLAFAXINE HCL 57 <11 <11 47 69
AMANTADINE 53 <11 <11 48 71
CYCLOBENZAPRINE HCL 52 <11 14 R 49 115
ZALEPLON 52 <11 11 49 80
DEXTROAMPHETAMINE-AMPHETAMINE 51 <11 <11 S2 51 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.